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Background: Client reminders are known to increase cancer screening attendance rates. However, there are
significant costs associated with them, and their effect by population size is unknown.
Methods: In 2007 and 2008, the Japanese Government surveyed breast and cervical cancer screening in every
municipality in Japan. From the results, we selected all 1,464 municipalities that carried out both screening types.
We examined whether changes in screening attendance rates between 2007 and 2008 were associated with client
reminders, number of public health nurses per 100,000 population, financial strength index, and 2007 attendance
rates for different population sizes. We then calculated cost-effectiveness estimates of client reminders by
population size and screening type.
Results: Client reminders were associated with increased attendance rates in populations <100,000. For populations of
50,000–100,000, there was a 2.76% increase in breast cancer screening (95% CI: 0.41, 5.11), and a 2.25% increase in
cervical cancer screening (95% CI: 0.89, 3.61). The incremental cost per additional attendance was higher in populations
<50,000 than in populations of 50,000–100,000 (breast, $100 versus $54; cervical, $149 versus $67 respectively).
Conclusions: Client reminders for breast and cervical cancer screening increased attendance rates in smaller
municipalities in Japan.
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Cancer is the leading cause of death in developed coun-
tries. Each year, breast and cervical cancers are respon-
sible for the deaths of around 41,000 and 4,000 women
in the United States and 12,000 and 1000 women in the
United Kingdom, respectively [1,2]. Breast cancer is one
of the most common cancers among Japanese women,
and accounts for the death of around 12,000 women
each year in Japan [3]. By contrast, the number of
women in Japan who die of cervical cancer each year is
only about 2,500 [3], but the increasing burden of this
cancer in young women has a huge impact on society.* Correspondence: komoto97@yahoo.co.jp
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reproduction in any medium, provided the orMany studies have reported that early detection and
treatment of breast and cervical cancers could reduce
their mortality [4-6]. Therefore, early detection screening
programs are widely implemented in many countries.
In Japan, screening guidelines recommend breast cancer
screening (mammography examinations) for women aged
over 40 years once every two years, and cervical cancer
screening (cervical cytology testing) for women aged over
20 years once every two years. Japanese people are asked
to make an effort to attend cancer screening. Despite this,
breast and cervical cancer screening attendance rates are
low. For example, only 24.3% of eligible women attended
screening for either cancer in 2010 [7].
To reduce breast and cervical cancer mortality in Japan,
increasing these low attendance rates has become an im-
portant issue. Based on the “Basic Law for the Promotionl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Labour and Welfare in Japan developed the “Plan to Cope
with Cancer,” and one of the main goals of this plan was
to raise cancer screening attendance rates to 50%. To help
meet this target, municipalities in Japan are searching for
effective measures to improve breast and cervical cancer
screening attendance rates.
Earlier studies found that effective measures for im-
proving screening attendance rates for these two types
of cancers included client reminders and one-on-one
education, with client reminders reported to have the
largest effect [1,4,8-14]. However, the effectiveness of
such measures may differ by population size, because that
affects the residents’ sense of belonging and the commu-
nity’s medical resources [15]. We therefore used survey
data from all municipalities in Japan that conduct both
breast and cervical cancer screening to assess the effect of
client reminders on screening attendance rates, and to
determine whether the effect varies by population size.
Each municipality is responsible for raising attendance
rates in their respective areas. Because budgets are lim-
ited they have to use cost-effective methods to achieve
this. It is therefore very important to estimate the effect
of client reminders, together with an estimate of their
cost per additional screening or to improve the percent-
age of the eligible population screened, by population
size and separately for each type of cancer.
Methods
Cancer screening survey
The survey about cancer screening activity was carried out
in 2007 and 2008 by the Japanese Ministry of Health,
Labour and Welfare (MHLW) [16,17]. It asked the admin-
istrative office of each municipality to report whether or
not they carried out cancer screening, how they selected
their target residents, and whether or not they sent
reminders. In both years, all municipalities (1,822 in 2007
and 1,818 in 2008) responded to the survey, a response
rate of 100%. For inclusion in our study, municipalities
had to have carried out both breast and cervical cancer
screening in 2007 and 2008, and not have merged with
another municipality during the period.
Based on whether or not client reminders were issued,
we divided the municipalities into four groups. Group 1
did not issue client reminders in 2007 or 2008. Group 2
issued client reminders in 2007 but not in 2008. Group
3 did not issue client reminders in 2007 but did in 2008.
Group 4 issued client reminders in both 2007 and 2008.
The subjects of this study were not individuals but every
municipality in Japan, so no ethical consent was needed.
Screening attendance rate estimation
We used the equation below to estimate the 2007 and
2008 screening attendance rates in each municipality.Cancer screening attendance rate %ð Þ
¼ ½ð number of cancer screening tests conducted in municipalityð Þ
= number of subjects in municipality eligible for cancer screeningð Þ
100
The numerator (number of cancer screening tests con-
ducted in municipality) was extracted from statistical
survey data collected every year by the MHLW [18,19].
The denominator (number of subjects in municipality
eligible for cancer screening) for breast cancer was the
total female population aged 40 or older, and for cervical
cancer, it was the total female population aged 20 or
older in each municipality [20]. Those who were offered
cancer screening by their workplace, so would not have
their test conducted in the municipality, and would
therefore not appear in the numerator, were also
excluded from the denominator.
Covariates
We obtained the number of public health nurses in each
municipality from statistical survey data [18,19] collected
every year by the MHLW, and calculated the number of
public health nurses per 100,000 people. We used the
Ministry of Internal Affairs and Communications’ statis-
tical surveys to obtain each municipality’s population
size and financial capability index. The financial capabil-
ity index is used to indicate the financial strength of
local public entities, and is calculated from the figures
provided by each municipality as the most recent three-
year average of the figures derived from dividing basic
financial earnings by basic financial needs [21,22].
Statistical analysis
We calculated the differences in attendance rates be-
tween 2007 and 2008 for breast and cervical cancer
screening, and then the average difference for each
group to identify whether sending reminders made any
difference to attendance. The average difference was
compared among the groups by using a multiple regres-
sion analysis. The adjusted differences and correspond-
ing 95% confidence intervals were calculated for each
group, with group 1 as a reference. We also looked for
correlations between attendance rate and various covari-
ates, including the attendance rate in 2007 (continuous),
the number of public health nurses per 100,000 popula-
tion, and the financial strength index. We divided the
latter two into four equal categories for analysis. We
repeated the regression analysis for different population
sizes. According to the Local Government Act in Japan,
municipalities with populations less than 50,000 are
defined as “towns”, and larger municipalities as “cities”.
The median population size among cities is 104,321 and so
we further divided cities into two almost equal groups using
a population point of 100,000, giving us three groups for
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100,000”, and “more than 100,000”.
Cost-effectiveness calculations
The primary outcomes of the cost-effective calculations
are values for “increased number of cancer screening
attendees” and “increased attendance rate for cancer
screening” in municipalities where client reminders were
carried out in 2008 but not in 2007. We estimated the
cost per single additional attendee and of increasing the
attendance rate by 1% for each population size category
and for the two types of cancer.
Municipalities generally inform their residents about
cancer screening using media such as public information
magazines and their website. However, no data was col-
lected about these more general methods. We therefore
could not compare the cost-effectiveness of individual
client reminders with different alternative interventions,
or estimate the effect of the more general methods.
The measured outcomes were “changes in numbers of
cancer screening attendees” and “changes in rate of can-
cer screening attendance” in the year of the intervention,
which is a more direct and immediate measure of suc-
cess than mortality rates. Earlier studies have already
proved that cancer screening can reduce the mortality rate
for breast cancer and cervical cancer [4-6], so the purpose
of this study is to identify suitable ways in which to
increase attendance, rather than to reduce mortality.
The cost of carrying out client reminders is the total
cost of posting individual reminders to all eligible resi-
dents. The cost of posting one individual reminder is
150 yen ($1.5 US, at exchange rates published on 5
September 2013) (this includes paper, printing, envelope
and personnel expenses at 70 yen, and a postage fee of
80 yen). It is considered that every municipality could
issue client reminders using the existing postage service,
without incurring any other costs.
To estimate the cost of increasing the attendance rate
by 1% for each population size category, we estimated
the cost of the 25th and 75th percentile population size
in each category. Because we investigated the short-term
change in attendance rates in the same year as an inter-
vention, we did not need to apply any discounting.
For the sensitivity analysis, we estimated the cost of
increasing attendance by one person and increasing the
attendance rate by 1% for each population size category
and for the two types of cancer.
Results
The distributions of population size, numbers of public
health nurses and financial capability index groups by cli-
ent reminder group are shown in Table 1. There were 644
(44.0%) municipalities that did not issue client reminders
in 2007. Of those, 168 issued client reminders in 2008.Table 2 shows breast and cervical cancer screening
attendance rates in 2007 and 2008 for each reminder
group, as well as the differences in attendance rates
between 2007 and 2008. Table 3 shows the results of the
multivariate analysis using the difference in attendance
rates as the dependent variable. When group 1 was used
as the reference, groups 3 and 4 had a larger increase in
attendance rates even after adjusting for covariates, with
the largest increase in group 3 (reminders introduced in
2008) for both breast and cervical cancer screening.
When we ran the analysis by population size, we observed
a statistically significant increase in the attendance rates of
groups 3 and 4 (compared with group 1) for breast cancer,
and for group3 for cervical cancer in populations of less
than 50,000 and in the rates of group 3 for both in popula-
tions between 50,000 and 100,000. The effect size was lar-
gest in populations between 50,000 and 100,000 (2.76%
for breast cancer [95% CI: 0.41, 5.11], 2.25% for cervical
cancer [95% CI: 0.89, 3.61]).
The degree of increase in attendance rate was associ-
ated with the previous level of attendance, i.e. the higher
the attendance rate in 2007, the smaller the increase in
attendance rate. As the number of public health nurses
per 100,000 population increased, the attendance rate
changed more markedly. In the same way, as the finan-
cial capability index categories increased, the attendance
rate changed more markedly. For both cancers, both
these associations were strongest in municipalities with
populations smaller than 50,000.
The cost-effectiveness estimates are shown in Table 4.
The incremental cost per additional screening in munici-
palities with populations fewer than 50,000 was $100 for
breast cancer screening and $149 for cervical cancer
screening. For populations between 50,000 and 100,000,
the costs were estimated at $54 for breast cancer screen-
ing and $67 for cervical cancer screening. Looking at the
data another way, the inter-quartile range for the cost of
increasing the attendance rate by 1% was from $2,041 to
$8,408 for breast cancer screening, and $3,030 and
$12,487 for cervical cancer screening in municipalities
with populations fewer than 50,000. In municipalities
with populations between 50,000 and 100,000, it was
between $9,229 and $12,867 for breast cancer screening,
and $11,321 and $15,783 for cervical cancer screening.
This suggests that breast cancer screening reminders
were more cost-effective than cervical cancer screening
reminders.
Discussion
From our findings, it seems likely that client reminders
can increase breast and cervical cancer screening attend-
ance rates, especially in municipalities with populations
fewer than 100,000. Client reminders were more cost-
effective in improving breast cancer screening attendance
















n % n % n % n % n %
Population Fewer than 50,000 14,926 306 64.3% 128 64.0% 125 74.4% 422 68.1% 981 67.0%
Between 50,000
and 100,000
67,181 88 18.5% 34 17.0% 17 10.1% 97 15.6% 236 16.1%






11.5 159 33.4% 60 30.0% 36 21.4% 143 23.1% 398 27.2%
Group 2
(16.1–26.1/100,000)
20.7 124 26.1% 42 21.0% 38 22.6% 162 26.1% 366 25.0%
Group 3
(26.2–43.3/100,000)
32.4 83 17.4% 48 24.0% 46 27.4% 176 28.4% 353 24.1%
Group 4
(≥43.4/100,000)




Group 1 (≤0.28) 0.21 108 22.7% 44 22.0% 48 28.6% 118 19.0% 318 21.7%
Group 2
(0.29–0.48)
0.38 98 20.6% 54 27.0% 45 26.8% 171 27.6% 368 25.1%
Group 3
(0.49–0.73)
0.60 127 26.7% 49 24.5% 36 21.4% 161 26.0% 373 25.5%
Group 4 (≥0.74) 0.93 143 30.0% 53 26.5% 39 23.2% 170 27.4% 405 27.7%
Significant correlations were identified between client reminders and population size (p = 0.015), number of public health nurses per population (p < 0.001) and
financial capability index (p = 0.030).
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marginal cost of increasing attendance ranged from $54 to
$149, depending on population size and cancer type.
Individual reminders are recommended by the US





































−0.21 2.88 −0.69 3.2
*p < 0.001 (Kruskal-Wallis test).breast and cervical cancer screening attendance rates [1].
Our results support this recommendation, particularly for
municipalities with populations fewer than 100,000. A re-
cent systematic review revealed that printed reminders
could increase breast cancer screening attendance rates bys in 2007 and 2008
t reminder group
Total







2.64) 10.68 (6.81–18.11) 11.89 (8.09–16.88) 10.10 (6.52–14.88)
1.52) 10.72 (6.40–17.80) 11.38 (7.7–16.52) 9.71 (6.04–14.56)
0 −0.26 5.27 −0.44 6.30 −0.45 5.74
5.82) 13.36 (8.36–19.90) 14.29 (9.84–20.54) 11.85 (8.12–17.41)
5.39) 13.18 (8.20–19.39) 14.52 (9.79–20.11) 11.62 (7.98–17.11)
7 0.22 4.24 −0.26 4.04 −0.25 3.63
Table 3 Factors associated with changes in breast and cervical cancer screening attendance rates by population size
Total
Population size











Reminders Group 1 (2007 no–2008 no) - - - - - - - -
Group 2 (2007 yes–2008 no) −0.60 (−0.46, 0.26) −0.42 (−1.62, 0.77) −0.43 (−2.20, 1.34) −0.92 (−2.11, 0.28)
Group 3 (2007 no–2008 yes) 1.24 (0.32, 2.16) ** 1.50 (0.28, 2.72) * 2.76 (0.41, 5.11) * −0.25 (−1.65, 1.14)
Group 4 (2007 yes–2008 yes) 1.13 (0.49, 1.77) ** 1.31 (0.43, 2.18) ** 0.72 (−0.64, 2.07) 0.84 (−0.10, 1.78)
2007 Attendance rates −0.35 (−0.39, -0.31) ** −0.38 (−0.43, -0.33) ** −0.30 (−0.40, -0.20) ** −0.20 (−0.29, -0.12) **
Number of public health nurses Group 1 (≤16.0/100 000) - - - -
Group 2 (16.1–26.1/100 000) 0.70 (−0.07, 1.48) 0.68 (−0.76, 2.13) 0.20 (−1.11, 1.51) −0.92 (−1.17, 0.99)
Group 3 (26.2–43.3/100 000) 1.01 (0.14, 1.89) * 0.94 (−0.53, 2.41) 0.62 (−1.21, 2.46) −0.88 (−2.80, 2.63)
Group 4 (≥43.4/100 000) 2.02 (0.99, 3.05) ** 1.94 (0.38, 3.51) * 1.98 (−6.83, 10.79) -
Financial strength index Group 1 (≤0.28) - - - -
Group 2 (0.29–0.48) 0.62 (−0.27, 1.51) 0.59 (−0.42, 1.60) 0.11 (−8.58, 8.81) -
Group 3 (0.49–0.73) 1.21 (0.23, 2.19) * 1.10 (−0.08, 2.29) 1.69 (−7.07, 10.44) −1.10 (−2.76, 0.56)
Group 4 (≥0.74) 1.62 (0.60, 2.63) ** 2.20 (0.92, 3.49) ** 1.45 (−7.32, 10.22) −0.97 (−2.60, 0.65)
Cervical cancer screening
Reminders Group 1 (2007 no–2008 no) - - - -
Group 2 (2007 yes–2008 no) −0.15 (−0.73,0.43) −0.03 (−0.84, 0.78) −0.25 (−1.30, 0.80) −0.41 (−1.34, 0.51)
Group 3 (2007 no–2008 yes) 0.95 (0.32, 1.57) ** 1.01 (0.18, 1.84) * 2.25 (0.89, 3.61) ** −0.37 (−1.44, 0.70)
Group 4 (2007 yes–2008 yes) 0.49 (0.06, 0.93) * 0.54 (−0.06, 1.14) 0.64 (−0.13, 1.42) 0.20 (−0.54, 0.94)
2007 Attendance rates −0.11 (−0.13, -0.09) ** −0.11 (−0.14, -0.08) ** −0.10 (−0.15, -0.05) ** −0.13 (−0.18, -0.08) **
Number of public health nurses Group 1 (≤16.0/100 000) - - - -
Group 2 (16.1–26.1/100 000) 0.10 (−0.41, 0.62) 0.26 (−0.73, 1.24) 0.04 (−0.73, 0.81) −0.76 (−1.60, 0.07)
Group 3 (26.2–43.3/100 000) 0.84 (0.26, 1.42) ** 1.05 (0.06, 2.05) * 0.00 (−1.07, 1.08) −0.26 (−2.36, 1.84)
Group 4 (≥43.4/100 000) 1.40 (0.71, 2.09) ** 1.58 (0.52, 2.64) ** 0.30 (−4.86, 5.47) -
Financial strength index Group 1 (≤0.28) - - - -
Group 2 (0.29–0.48) 0.69 (0.09, 1.29) * 0.61 (−0.08, 1.30) −0.01 (−5.13, 5.10) -
Group 3 (0.49–0.73) 1.38 (0.71, 2.04) ** 1.38 (0.57, 2.18) ** 0.06 (−5.09, 5.20) −0.29 (−1.57, 0.99)
Group 4 (≥0.74) 2.19 (1.50, 2.88) ** 2.67 (1.80, 3.54) ** 0.72 (−4.43, 5.87) −0.10 (−1.35, 1.15)


























































25% 6,917 2,041 1.5 3.1 1.5 31 100 2,041
Median 14,926 4,403 1.5 6.6 1.5 66 100 4,403
75% 28,501 8,408 1.5 12.6 1.5 126 100 8,408
Population between
50 000 and 100 000
25% 57,566 16,982 1.5 25.5 2.76 469 54 9,229
Median 67,181 19,818 1.5 29.7 2.76 547 54 10,771







25% 6,917 2,041 1.5 3.1 1.01 21 149 3,030
Median 14,926 4,403 1.5 6.6 1.01 44 149 6,539
75% 28,501 8,408 1.5 12.6 1.01 85 149 12,487
Population between
50 000 and 100 000
25% 57,566 16,982 1.5 25.5 2.25 382 67 11,321
Median 67,181 19,818 1.5 29.7 2.25 446 67 13,212
75% 80,255 23,675 1.5 35.5 2.25 533 67 15,783
aBreast cancer screening is offered to women older than 40 years (29.5% of the population), and cervical cancer screening to women older than 20 years (42.3% of the population).
b1 US dollar =100 yen.
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ment (1.24%) observed across all municipalities in this
study falls below this. However, the 2.76% increase ob-
served in municipalities with populations between 50,000
and 100,000 is closer to that figure.
For cervical cancer screening attendance rates, in our
study, an improvement of 0.95% was observed across all
municipalities, and an improvement of 2.25% was ob-
served in municipalities with populations between 50,000
and 100,000. These figures fall well short of that estimated
for cervical cancer in the systematic review (10.2%, IQI =
6.3, 17.9) [8]. There are two possible reasons for the
smaller effect of client reminders observed in our study.
First, it is possible that the risk of cervical cancer is not
common knowledge among those in their 20s, because
the target population for cervical cancer screening in
Japan did not include women younger than 30 years old
until 2004. This could result in a smaller increase in the
cervical cancer screening attendance rate. Second, the
client reminders were mainly sent via post in Japan,
whereas some of the reminders examined in the system-
atic review were issued by phone instead, which might
have greater impact.
Client reminder effects were seen in small but not large
municipalities. This could be because strong social net-
works promote medical check-ups in small municipalities
[15]. The sense of ‘belonging’ is higher among residents of
small municipalities, and they are therefore more likely to
have a stronger response to encouragement from their
municipality. In addition, in large municipalities, there are
many medical institutions where residents can freely
receive consultations. Residents may therefore use cancer
screening services provided by these medical institutions,
instead of the services provided by the municipality. Such
cancer screenings were not counted in our survey, because
they were not provided by municipalities. Our study could
therefore be underestimating both the actual numbers of
screenings and the efficacy of reminders in these large
municipalities.
A previous study showed that sending out individual
or customized reminder letters improved cervical cancer
screening attendance rates by 9.4%, whereas no signifi-
cant improvement was seen when routine reminder
letters were sent [9]. Customized reminders may have
been included among those issued by municipalities in
our survey, but this information was not collected. We
may be able to increase the effectiveness of reminders by
customizing them, but it is extremely difficult to create
individually-customized reminders, and there are few
cancer screening experts in the municipalities of Japan
to do so.
In municipalities in Japan, public health nurses con-
duct cancer screening. They are also in charge of various
services such as infant health check-ups and providingmeasures against infectious diseases like tuberculosis.
Our results show that the more public health nurses per
population, the stronger the effect of the reminders in
increasing cancer screening attendance rates. This could
simply be the effect of more appointments and clinics
being available for cancer screening, or it could be related
to increased familiarity with, and therefore acceptance of,
the role of public health nurses, leading to increased likeli-
hood of eligible women taking up the opportunity for
screening tests. Further investigation would be necessary
to establish the precise links between numbers of nurses
per population and cancer screening increases.
The financial burden on municipalities of providing
cancer screening services is large. Our results suggest
that wealthier municipalities may devote more of their
budget to cancer screening, and that this is then associ-
ated with higher attendance rates.
An intervention study of 6,133 women, carried out in
North West London and the West Midlands in the
United Kingdom, reported that the incremental cost per
additional breast cancer screening of sending reminders
by post was £26 (approximately $41.8, at current ex-
change rates) [12]. In our study, in municipalities with
populations between 50,000 and 100,000, the cost per
additional breast cancer screening was $54. However, in
the UK study, the attendance rate in the non-intervention
group was 55.3%, and in the intervention group was
64.4%, which is five times higher than Japanese attendance
rates, and thus cannot easily be compared with our study.
This study was strengthened by the strong reliability of
the information sources and the 100% response rate of all
municipalities conducting cancer screening in Japan.
Furthermore, the information about client reminders and
covariate data were obtained separately from attendance
rates, strengthening the data. However, this study has sev-
eral limitations. We were unable to investigate the effects
of individual methods such as post versus telephone
reminders, because the details of the client reminder
methods used by each municipality were unclear. We
were also unable to investigate the effect of personal char-
acteristics on screening attendance, because we did not
have any information on individual residents such as past
consultation history, educational background, and income.
For instance, the effect of reminders in the form of letters
is reported to be stronger in groups who have previously
had a mammogram or cervical cancer cytology test than
in those who have never been screened [10,11]. In this
study, we could not investigate whether this was the case
because of the lack of information on past consultation
history. If this was true, we believe that it could be possible
to increase cost-effectiveness by only sending out reminders
to those who have a previous history of consultations
[4,10,13]. However, such an approach, although perhaps
more cost-effective, would have considerable ethical issues,
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being used to reach out to those who had not previously
attended. By collecting more information about individuals
and reminder methods, we could investigate more effective
ways to increase participation in cancer screening.
Japan's screening attendance rate is much lower than
those of Western countries, so our results are thought to
be more applicable to regions with low attendance rates,
and to countries that aim to implement cancer screening
in the future.
This study provides valuable information to staff in
charge of cancer screening tests in municipalities, to
help them decide whether to issue client reminders. On
the basis of our findings, we recommend that they should
do so, especially in municipalities with population size up
to 100,000, and for breast cancer screening.Conclusions
In conclusion, we saw an improvement in the 2008 breast
and cervical cancer screening attendance rates in munici-
palities that issued client reminders. The improvements
were most obvious in municipalities with populations
fewer than 100,000. Improving breast cancer screening
attendance rates was more cost-effective than improving
cervical cancer screening rates.
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